The Emerging Role of [89Zr]Zr-DFO-Girentuximab PET/ CT in Accurate Characterisation and Staging of ccRCC: early experience with three Patients

被引：0
|
作者：
Gelardi, F. [1 ,2 ]
Antunovic, L. [2 ]
Larcher, A. [1 ,2 ]
Musso, G. [1 ,2 ]
Re, C. [1 ,2 ]
Cei, F. [1 ,2 ]
Belladelli, F. [1 ,2 ]
Salonia, A. [1 ,2 ]
Luciano, R. [1 ,2 ]
Tenace, N. [1 ,2 ]
Olivieri, M. [1 ,2 ]
Savi, A. [2 ]
Sollini, M. [1 ,2 ]
Chiti, A. [1 ,2 ]
机构：
[1] Univ Vita Salute San Raffaele, Milan, Italy
[2] IRCCS Osped San Raffaele, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-824
引用
收藏
页码：S395 / S395
页数：1
相关论文
共 40 条
  • [1] Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
    Verhoeff, Sarah R.
    van Es, Suzanne C.
    Boon, Eline
    van Helden, Erik
    Angus, Lindsay
    Elias, Sjoerd G.
    Oosting, Sjoukje F.
    Aarntzen, Erik H.
    Brouwers, Adrienne H.
    Kwee, Thomas C.
    Heskamp, Sandra
    Hoekstra, Otto S.
    Verheul, Henk
    van der Veldt, Astrid A. M.
    de Vries, Elisabeth G. E.
    Boerman, Otto C.
    van der Graaf, Winette T. A.
    Oyen, Wim J. G.
    van Herpen, Carla M. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (09) : 1931 - 1939
  • [2] Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
    Sarah R. Verhoeff
    Suzanne C. van Es
    Eline Boon
    Erik van Helden
    Lindsay Angus
    Sjoerd G. Elias
    Sjoukje F. Oosting
    Erik H. Aarntzen
    Adrienne H. Brouwers
    Thomas C. Kwee
    Sandra Heskamp
    Otto S. Hoekstra
    Henk Verheul
    Astrid A. M. van der Veldt
    Elisabeth G. E. de Vries
    Otto C. Boerman
    Winette T. A. van der Graaf
    Wim J. G. Oyen
    Carla M. L. van Herpen
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1931 - 1939
  • [3] Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP)
    Nakaigawa, Noboru
    Hasumi, Hisashi
    Utsunomiya, Daisuke
    Yoshida, Keisuke
    Ishiwata, Yoshinobu
    Oka, Takashi
    Hayward, Colin
    Makiyama, Kazuhide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (08) : 873 - 879
  • [4] Radiation protection considerations with [89Zr]Zr-girentuximab PET/CT experience in France
    Morgat, C.
    Bailly, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S223 - S223
  • [5] Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma
    Schembri, G. P.
    Yin, C.
    Willowson, K.
    Hedt, A.
    Lengyelova, E.
    Parker, M.
    Biggin, C.
    Harris, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S67 - S68
  • [6] [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
    Verhoeff, Sarah R.
    Oosting, Sjoukje F.
    Elias, Sjoerd G.
    van Es, Suzanne C.
    Gerritse, Sophie L.
    Angus, Lindsay
    Heskamp, Sandra
    Desar, Ingrid M. E.
    van Oordt, C. Willemien Menke-van der Houven
    van der Veldt, Astrid A. M.
    Arens, Anne I. J.
    Brouwers, Adrienne H.
    Eisses, Bertha
    Mulders, Peter F. A.
    Hoekstra, Otto S.
    Zwezerijnen, Gerben J. C.
    van der Graaf, Winette T. A.
    Aarntzen, Erik H. J. G.
    Oyen, Wim J. G.
    van Herpen, Carla M. L.
    CLINICAL CANCER RESEARCH, 2023, 29 (03) : 592 - 601
  • [7] Comparison of [89Zr]Zirconium-DFO-girentuximab (89Zr-TLX250) PET/CT and PET/MRI hybrid systems in patients with suspicion of Clear Cell Renal Cell Carcinoma (ccRCC): Initial results
    Liu, Chen
    Xie, Qing
    Zhang, Yan
    Ma, Yunxia
    Liu, Shiwei
    Cerqueira, Brenda
    Brown, Tracey
    Tang, Weikun
    Du, Peng
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [8] 89Zr-DFO-GIRENTUXIMAB FOR PET/CT IMAGING OF CLEAR CELL RENAL CELL CARCINOMA (ccRCC)-RESULTS FROM PHASE 3 ZIRCON STUDY
    Martina, Stefanie
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 38 - 38
  • [9] [89Zr]Zr-girentuximab PET-CT imaging to diagnose, characterize, and differentiate clear-cell renal cell carcinoma
    Chehade, Chadi Hage
    Gebrael, Georges
    Agarwal, Neeraj
    MED, 2024, 5 (11): : 1345 - 1347
  • [10] Acquisition and reconstruction protocol for [89Zr] Z-DFO-girentuzimab studies on BGO based PET/CT system
    Olivieri, M.
    Antunovic, L.
    Gelardi, F.
    Larcher, A.
    Sollini, M.
    Salonia, A.
    Chiti, A.
    Savi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S336 - S336
1234